Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
Phase 2
37
about 2.8 years
18+
1 site in OH
What this study is about
Researchers are testing if lattice radiation therapy (LRT) can provide better treatment for bulky tumors than current standard radiotherapy. The trial will involve 37 patients receiving 5 fractions of LRT every other day over a period of approximately 10 months. The main goals are to see how well LRT works and what side effects occur.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Lattice therapy (LRT)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Adverse Events, Overall Response Rate
Secondary: Overall Survival, Patient-reported Quality of Life
Oncology